Dear Doctor - Participate in the Survey on probiotics" A new survey has found that the use of probiotics is on the rise, with more people than ever before using these supplements to improve their gut health. The survey, which was conducted by the American Gastroenterological Association, found that nearly 40% of respondents had used probiotics in the past year. This is a significant increase from previous surveys, which found that only 20-25% of people were using probiotics.There are many different reasons why people may be taking probiotics, but the most common reason is to improve digestive health. Probiotics are live bacteria and yeasts that are good for your gut, and they can help to restore the balance of microbes in your gut if it has been disrupted. Probiotics are often taken to help with conditions like irritable bowel syndrome (IBS), diarrhea, and Crohn's disease.If you're thinking about taking probiotics, it's important to talk to your doctor first. Probiotics are generally safe for most people, but there are some potential side effects, and they may not be appropriate for everyone. Participate in Surveys "
1.
Video: Liver transplant for patients with advanced colorectal cancer
2.
La interacción GBP3-STING en el glioblastoma coordina la respuesta deficiente al temozolomide.
3.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
4.
AI is useful in low-resource areas for triaging breast masses.
5.
Does pollution cause cancer?
1.
Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review
2.
Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine
3.
Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense
4.
Unlocking the Potential of Onivyde: A New Hope for Cancer Treatment
5.
Beyond the Cure: The Emerging Role of Tissue-Agnostic Therapies in Palliative Oncology
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
4.
Navigating the Complexities of Ph Negative ALL - Part VII
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation